| UniProt/SwissProt ID: | H4_HUMAN |
| Description: | histone cluster 1, H4c [Source:HGNC Symbol;Acc:4787] |
| Location: | chr6 p22.2 |
| Node attribute: | gene |
|
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|
| T74 | DAVTYtEHAKR | Histone | PhosphoSitePlus |
| T83 | KRKTVtAMDVV | Histone | PhosphoSitePlus |
| T83 | KRKTVtAMDVV | | HPRD |
| S2 | ____MsGRGKG | | PhosphoSitePlus |
| T81 | HAKRKtVTAMD | | HPRD |
| Y89 | AMDVVyALKRQ | Histone | PhosphoSitePlus |
| Y73 | RDAVTyTEHAK | Histone | PhosphoSitePlus |
| Y99 | QGRTLyGFGG_ | | PhosphoSitePlus |
| Y52 | ISGLIyEETRG | Histone | PhosphoSitePlus |
| T81 | HAKRKtVTAMD | Histone | PhosphoSitePlus |
| S48 | GVKRIsGLIYE | | HPRD; phosphoELM; SysPTM |
| S2 | RGKG | | phosphoELM |
| S48 | GVKRIsGLIYE | Histone | PhosphoSitePlus; SysPTM |
| Y52 | ISGLIyEETRG | | HPRD; phosphoELM |
| Y89 | AMDVVyALKRQ | | HPRD; phosphoELM |
| T31 | NIQGItKPAIR | Histone | PhosphoSitePlus |
| T55 | LIYEEtRGVLK | Histone | PhosphoSitePlus |
|
H4_HUMAN do not have dephosphorylation site.
|
|
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|
| ENSP00000358162 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000350767 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000347168 | R96L | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000376663 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000353624 | E54D | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000367034 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000348258 | K13I | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000350767 | R37C | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000350767 | R40Q | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000343282 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000346316 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000353624 | R79H | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000367034 | A70T | COSMIC | Skin Cancer | 21984974 |
| ENSP00000358153 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000353624 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000353624 | N26I | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000352980 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000343282 | K9R | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000366956 | V88F | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000366581 | R40M | COSMIC | Ovarian Cancer | 20826764 |
| ENSP00000347168 | R96L | TCGA | Ovarian Cancer | 21720365, 18772890 |
| ENSP00000366974 | R4K | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000289352 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000350159 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000366581 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000346316 | R24H | COSMIC | Pancreatic Cancer | 18772397 |
| ENSP00000366956 | S2C | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000366956 | R40G | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000347168 | G10R | COSMIC | Pancreatic Cancer | |
| ENSP00000366956 | A16V | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000366974 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000366956 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000376668 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000348258 | D25N | COSMIC | Ovarian Cancer | 21720365 |
| ENSP00000366581 | R68W | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000376664 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000347168 | E64Q | HPI | Breast Cancer | 16959974 |
| ENSP00000348258 | E64Q | Sjoblom2006, COSMIC, HPI | Breast Cancer | 16959974 |
| ENSP00000353624 | K80N | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000376669 | E64Q | HPI | Breast Cancer | 16959974 |
|
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|
| ENSP00000376663 | Hepatocellular Carcinoma | Normal vs. Cancer | cell line | Up | 5.3 | 18646787 |
| ENSP00000376663 | Breast Cancer | Treatment (none vs. 17b-Estradiol treatment) | cell line | Up | 2.3 | 18491314 |
| ENSP00000376663 | Gastric Cancer | Treatment (none vs. drug-resistant) | cell line | Down | 0.53 | 20625496 |
|
| Site | Motif | Peptide | Cancer name | Pubmed | Source |
|---|
| Y73 | Histone | VIRDAVTyTEHAKRK | cholangiocellular carcinoma | 21253578 | PhosphoSitePlus |
|
H4_HUMAN is not in KEGG pathway.
|
|
| GO ID | GO_Term | Evidence | Ontology |
|---|
| GO:0006352 | DNA-dependent transcription, initiation | IEA | biological_process |
| GO:0048015 | phosphatidylinositol-mediated signaling | NAS | biological_process |
| GO:0005730 | nucleolus | IDA | cellular_component |
| GO:0045653 | negative regulation of megakaryocyte differentiati | IDA | biological_process |
| GO:0015629 | actin cytoskeleton | IDA | cellular_component |
| GO:0005515 | protein binding | IEA | molecular_function |
| GO:0005576 | extracellular region | TAS | cellular_component |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0034080 | CENP-A containing nucleosome assembly at centromer | TAS | biological_process |
| GO:0005634 | nucleus | IDA | cellular_component |
| GO:0000723 | telomere maintenance | TAS | biological_process |
| GO:0005654 | nucleoplasm | TAS | cellular_component |
| GO:0046982 | protein heterodimerization activity | IEA | molecular_function |
| GO:0003677 | DNA binding | TAS | molecular_function |
| GO:0006325 | chromatin organization | NAS | biological_process |
| GO:0000786 | nucleosome | TAS | cellular_component |
| GO:0006334 | nucleosome assembly | TAS | biological_process |
|
Fatal error: Uncaught Error: Call to undefined function mysql_close() in /usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php:23
Stack trace:
#0 /usr/local/apache/htdocs/PhoSigNet/proteintable.php(435): db_disconnect(Object(mysqli))
#1 {main}
thrown in
/usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php on line
23